What is Protenus?
Founded in 2014 and headquartered in Baltimore, Maryland, Protenus specializes in safeguarding patient privacy within complex electronic health record environments. By leveraging advanced data science, machine learning, and behavioral analytics, the company provides a critical layer of oversight that monitors clinical behavior to detect unauthorized access or inappropriate data usage. As a pivotal player in the health-tech sector, Protenus addresses the growing demand for automated compliance and security solutions in large-scale healthcare delivery systems, effectively bridging the gap between clinical operations and data integrity.
How much funding has Protenus raised?
Protenus has raised a total of $52.6M across 7 funding rounds:
Other Financing Round
$50K
Debt
$770K
Other Financing Round
$150K
Series A
$2.6M
Series B
$11M
Series C
$17M
Series D
$21M
Other Financing Round (2014): $50K with participation from Dream iT Ventures
Debt (2014): $770K, investors not publicly disclosed
Other Financing Round (2015): $150K supported by Tedco
Series A (2016): $2.6M featuring Baltimore Angels, LionBird Venture Capital, Tedco, Dreamit Ventures, Arthur Ventures, and Cognosante
Series B (2018): $11M backed by Arthur Ventures, Lionbird Venture Capital, F-Prime Capital Partners, and Kaiser Permanente Ventures
Series C (2019): $17M with participation from Kaiser Permanente Ventures, Providence Ventures, F-Prime Capital, Lionbird, Arthur Ventures, and LTP
Series D (2021): $21M led by LionBird, Gaingels, Kaiser Permanente Ventures, Providence Ventures, MemorialCare Innovation Fund, Arthur Ventures, Transformation Capital, and F-Prime Capital Partners
Key Investors in Protenus
F-Prime Capital Partners
A global venture capital firm with a dedicated team of investors, engineers, and scientists focused on driving innovation within the healthcare and technology sectors.
Kaiser Permanente Ventures
The strategic venture arm of a national healthcare leader, focusing on investments that provide clear value for patients, providers, and healthcare delivery systems.
Arthur Ventures
An early growth capital firm specializing in leading investments for B2B software companies across the U.S. and Canada, with a focus on maximizing enterprise value.
What's next for Protenus?
Following its latest major strategic investment, Protenus is well-positioned to accelerate its enterprise-level expansion. The company is expected to focus on deepening its technological moat by enhancing its predictive analytics capabilities and expanding its footprint within the U.S. healthcare market. By maintaining strong relationships with its core investor base, Protenus is poised to continue its trajectory as a standard-bearer for privacy-centric innovation, likely targeting further integration into national healthcare delivery networks to mitigate the risks associated with digital health data exposure.
See full Protenus company page
